Jenoptik achieves ‘record’ trading in second quarter - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Jenoptik achieves ‘record’ trading in second quarter

    Article obtained from RSS Feed.

    Guidance for 2021 raised as both revenue and order intake increase significantly.

    Jul, 22 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.